It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 Kyoto University, Graduate School of Pharmaceutical Sciences, Laboratory of Molecular Metabology, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033); The University of Manchester, Faculty of Biology, Medicine and Health, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407)
2 Kyoto University, Graduate School of Pharmaceutical Sciences, Laboratory of Molecular Metabology, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
3 Kyoto University, Graduate School of Pharmaceutical Sciences, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
4 Kyoto University, Graduate School of Pharmaceutical Sciences, Department of System Chemotherapy and Molecular Sciences, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
5 University of Münster, Institute of Neuro- and Behavioral Biology, Münster, Germany (GRID:grid.5949.1) (ISNI:0000 0001 2172 9288)
6 University of Edinburgh, School of Biological Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
7 University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences, Los Angeles, USA (GRID:grid.19006.3e) (ISNI:0000 0000 9632 6718)
8 Vanderbilt University, Department of Biological Sciences, Nashville, USA (GRID:grid.152326.1) (ISNI:0000 0001 2264 7217)
9 Karolinska Institute, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
10 National University of Quilmes/CONICET, Department of Science and Technology, Buenos Aires, Argentina (GRID:grid.11560.33) (ISNI:0000 0001 1087 5626)
11 Kyoto University, Institute for Frontier Life and Medical Sciences, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
12 University College London, Centre for Cell and Molecular Dynamics, Department of Cell and Developmental Biology, London, UK (GRID:grid.83440.3b) (ISNI:0000000121901201)
13 The Hospital for Sick Children, Molecular Medicine, Peter Gilgan Centre for Research and Learning (PGCRL), Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646)
14 The Hospital for Sick Children, Molecular Medicine, Peter Gilgan Centre for Research and Learning (PGCRL), Toronto, Canada (GRID:grid.42327.30) (ISNI:0000 0004 0473 9646); University of Toronto, Department of Biochemistry, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938)
15 Nagoya University, Center for Gene Research, Nagoya, Japan (GRID:grid.27476.30) (ISNI:0000 0001 0943 978X)
16 Kyoto University, Graduate School of Pharmaceutical Sciences, Laboratory of Molecular Brain Science, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033); Kyoto University, Graduate School of Medicine, Department of Neuroscience, Division of Physiology and Neurobiology, Yoshida-Konoe-cho, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)